Breakthrough malaria vaccine proves 77% effective
Researchers from the University of Oxford and their partners on Friday reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up. In their findings published in the…